Echocardiographic, Electrocardiographic Changes and Clinical Outcomes of Patients Who Respond to Cardiac Resynchronization Therapy after One Year.

about

Echocardiographic, Electrocardiographic Changes and Clinical Outcomes of Patients Who Respond to Cardiac Resynchronization Therapy after One Year.

Item

http://www.wikidata.org/entity/Q41123622

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Echocardiographic, Electrocard ...... zation Therapy after One Year.

@en

type

Item

label

Echocardiographic, Electrocard ...... zation Therapy after One Year.

@en

prefLabel

Echocardiographic, Electrocard ...... zation Therapy after One Year.

@en

P1476

Echocardiographic, Electrocard ...... zation Therapy after One Year.

@en

P2093

Hae Ok Jung

http://www.w3.org/2001/XMLSchema#string

Ho-Joong Youn

http://www.w3.org/2001/XMLSchema#string

Jaeho Byeon

http://www.w3.org/2001/XMLSchema#string

Mi-Hyang Jung

http://www.w3.org/2001/XMLSchema#string

Young Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac resynchronization in chronic heart failure.

Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome.

The problem of non-response to cardiac resynchronization therapy.

Meta-analysis of effects of optimization of cardiac resynchronization therapy on left ventricular function, exercise capacity, and quality of life in patients with heart failure.

QRS duration shortening predicts left ventricular reverse remodelling in patients with dilated cardiomyopathy after cardiac resynchronization therapy.

QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure.

Long-Term Echocardiographic Response to Cardiac Resynchronization Therapy in Initial Nonresponders.

Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrio

Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes.

Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

P304

63-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4250/JCU.2017.25.2.63

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28770034

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

electrocardiography

P932

5526887

http://www.w3.org/2001/XMLSchema#string